article thumbnail

STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database

STAT

The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5

article thumbnail

Deep Dive: Digital Health 2021

pharmaphorum

Healthcare companies have a unique opportunity to develop digital health beyond the pandemic bubble says Healthware Group CEO Roberto Ascione at the 2021 Frontiers Health conference in Milan. At the 2021 Frontiers Health conference in Milan, Mark Duman and Paul Tunnah discuss the importance of co-creating with patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nine for 2021: The COVID-19 legacy

pharmaphorum

In the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical industries in 2021. One bright spot in an otherwise dreadful year: the pharmaceutical industry has discovered it can do things it never dreamed possible.

Hospitals 105
article thumbnail

5 Trends That Will Shape Pharma Marketing in 2021

Pharma Marketing Network

Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Tools that help people track their health, including apps, wearables, and patient portals will be used more than ever in 2021. Source: What Matters Most: The Trends That Will Shape Pharma Marketing in 2021.

article thumbnail

A Win for Indiana Patients: “Share the Savings” Legislation Now Law

PhRMA

Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM.

article thumbnail

Steep drop for UK industry clinical trials between 2017 and 2021

European Pharmaceutical Review

The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). million people living with rare diseases in the UK.

article thumbnail

Novo Nordisk industry membership reinstated

European Pharmaceutical Review

Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021.